NAYA Biosciences, Inc (NAYA) Stock
NAYA is no longer traded. NAYA Biosciences was delisted from the Nasdaq in April 2025.
Prices on this page are historical; the last trade was April 25, 2025 at $2.20.
NAYA Biosciences stock price history
NAYA final trading statistics
- Final close
- $2.20
- Final trading day
- Apr 25, 2025
- Market cap at delisting
- $2.48M
- Shares outstanding
- 4.48M
- Final 52-week range
- $0.19 – $2.75
- Avg. volume (final 3 mo.)
- 59,000
- All-time high (split-adj.)
- $53760.00 · Nov 2008
- All-time low (split-adj.)
- $1.72 · Apr 2025
- Return since IPO
- -99.9%
- Beta
- —
- Book value / share
- -$3.91
- Price / book
- -0.56
NAYA Biosciences annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $6.53M | -$9.1M | — |
| FY2023 | $3.02M | -$8.0M | — |
| FY2022 | $822.2K | -$10.9M | — |
| FY2021 | $4.16M | -$6.7M | — |
| FY2020 | $1.04M | -$8.3M | — |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About NAYA Biosciences, Inc
INVO Fertility, Inc., a life science portfolio company, develops clinical stage assets to treat patients with fertility, oncology, and autoimmune diseases. The company operates in two divisions, NAYA Women's Health and NAYA Therapeutics. Its lead product includes NY-303, a GPC3-targeted FLEX-NK bispecific antibody that is in Phase I/II clinical trials for hepatocellular carcinoma, as well as solid and pediatric tumors; and NY-338, a CD38-targeted FLEX-NK bispecific antibody for multiple myeloma and autoimmune diseases. The company also offers INVOcell, a a revolutionary medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in April 2025. INVO Fertility, Inc. was founded in 2007 and is based in Sarasota, Florida.
NAYA Biosciences stock FAQ
What happened to NAYA Biosciences stock?
NAYA Biosciences stock was delisted from the Nasdaq. Its final close was $2.20 on April 25, 2025.
Is NAYA stock still trading?
No. NAYA was delisted from the Nasdaq in April 2025 and no longer trades on a U.S. exchange.
What was the last price of NAYA stock?
NAYA closed at $2.20 on its final trading day, April 25, 2025, for a market value of about $2.48M.
What were NAYA Biosciences's revenue and earnings in its last full fiscal year?
NAYA Biosciences reported revenue of $6.53M and net income of -$9.1M in fiscal 2024, its last full year as a public company.
When did NAYA Biosciences go public?
NAYA Biosciences, Inc stock began trading on May 21, 2012.